SYRACUSE, N.Y. — An Ithaca firm won the top funding prize at FuzeHub’s commercialization competition during the New York State Innovation Summit held Monday and Tuesday at the Nicholas J. Pirro Convention Center at Oncenter in Syracuse.
In addition, a business that has operations at the CNY Biotech Accelerator in Syracuse also won a funding award as well.
Anova Biomedical of Ithaca won the first-place prize of $150,000, and Triton Bio of Syracuse was among five companies winning $50,000.
(Sponsored)
ESOP Benefits for Architecture and Engineering Firms
Planning an exit strategy from your successful architecture or engineering firm can be difficult at times. While there are many options to choose from, one that many companies fail to
Time to Prepare for OSHA’s new “Walkaround Rule”
In a development consistent with President Biden‘s growing reputation as leading the most pro-union administration in history, the Occupational Safety and Health Administration (OSHA) has published a rule allowing employees
FuzeHub, an Albany–based nonprofit, connects New York’s small and mid-sized manufacturing companies to the resources, programs, and expertise they need for technology commercialization, innovation, and business growth.
The competition occurs yearly as part of the Empire State Development-supported FuzeHub Jeff Lawrence Innovation Fund.
This year, FuzeHub used additional funding from Gov. Kathy Hochul’s office to award funding to even more startups and introduce a runner-up level as well.
A total of 12 entrepreneurs from across New York state competed for a chance to win $50,000 by pitching their business plans to a panel of judges, with a grand prize award of $150,000.
The Anova Biomedical product
Anova Biomedical is developing a vascular graft that will “revolutionize the standard of care” for patients, per the description in the FuzeHub announcement.
“When an artery is blocked, rerouting blood flow with a vascular graft (or blood vessel replacement) can save patient lives and limbs. Vascular grafts used in hospitals today are made using materials that stay in the body forever, causing problems like infection, clot formation, and inflammation. Each of these problems causes pain and suffering for the patient, requires frequent medical intervention, and puts lives at risk. Anova grafts are made using an entirely new material that is infection resistant and prevents clot formation,” as described by FuzeHub.
The Triton Bio product
Imagine having a front-row seat to the hidden drama of microbial life – that’s what Triton Bio delivers, per the FuzeHub announcement. Its newly launched Mira Smart Incubator captures microorganisms “in action and in stunning detail” over days or even weeks.
Using the Mira system, microbiologists will “gain an unprecedented view into the dynamic world” of microorganisms.
“With this revolutionary product, microbiologists will discover new antibiotics and probiotics, improve food preservation and safety measures, engineer microbes that clean up pollution or produce sustainable materials, and optimize brewing and fermentation processes,” as described in the FuzeHub news release.
